Reportlinker Adds Baxter International Inc.: PharmaVitae Profile

News provided by

Jan 13, 2011, 08:32 ET

NEW YORK, Jan. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Baxter International Inc.: PharmaVitae Profile

http://www.reportlinker.com/p0360225/Baxter-International-Inc-PharmaVitae-Profile.html

Introduction

This analysis examines the historical and forecast performance for Baxter in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits

* Gain insight into Baxter's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Highlights

Strategic insight into the prospects for Baxter over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Your key questions answered

* Benchmark Baxter's performance against key rivals in the prescription pharmaceutical sector* Assess the importance of Baxter's 'wild card' Gammagard for Alzheimer's disease, currently in Phase III trials, in driving sales growth out to 2015

To order this report:

: Baxter International Inc.: PharmaVitae Profile

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!